- cafead   Apr 09, 2018 at 10:02: AM
via The article discusses the concern over the number of deaths (244) and other adverse events linked to nuplazid. The drug was approved in April of 2016 as a much needed treatment for Parkinson's disease psychosis.
article source
article source